Kezar Life Sciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$3.33 | -$3.33 | -$3.33 |
| Q2 2024 | 1 | -$3.20 | -$3.20 | -$3.20 |
| Q3 2024 | 1 | -$3.15 | -$3.15 | -$3.15 |
| Q4 2024 | 3 | -$3.10 | -$1.87 | -$2.74 |
| Q1 2025 | 1 | -$2.70 | -$2.18 | -$2.45 |
| Q2 2025 | 1 | -$2.34 | -$2.34 | -$2.34 |
| Q3 2025 | 1 | -$2.22 | -$2.22 | -$2.22 |
| Q4 2025 | 1 | -$2.20 | -$2.20 | -$2.20 |
| Q1 2026 | 1 | -$2.85 | -$2.85 | -$2.85 |
| Q2 2026 | 1 | -$2.93 | -$2.93 | -$2.93 |
| Q3 2026 | 1 | -$3.00 | -$3.00 | -$3.00 |
| Q4 2026 | 1 | -$3.08 | -$3.08 | -$3.08 |
Kezar Life Sciences, Inc. Earnings Date And Information
Kezar Life Sciences, Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-2.8 earnings per share for the quarter, topping analysts' consensus estimates of $-3.2 by $0.4. The company had revenue of 0 for the quarter and had revenue of 7.00 M for the year. Kezar Life Sciences, Inc. has generated $-1 earnings per share over the last year ($-1.4 diluted earnings per share) and currently has a price-to-earnings ratio of -5.63. Kezar Life Sciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based on prior year's report dates.
Kezar Life Sciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.28 | $800,000 | $0 | ||
| 08/13/2024 | Q2 2024 | -$3.20 | -$2.96 | 0.24 | $750,000 | $0 |
| 05/09/2024 | Q1 2024 | -$3.40 | -$0.30 | 3.1 | $0 | |
| 03/14/2024 | Q4 2023 | -$3.90 | -$0.44 | 3.46 | $-5,428,000 | |
| 11/13/2023 | Q3 2023 | -$3.60 | -$0.32 | 3.28 | $166,667 | $7.00 M |
| 08/10/2023 | Q2 2023 | -$3.30 | -$0.34 | 2.96 | $0 | |
| 05/11/2023 | Q1 2023 | -$2.80 | -$0.28 | 2.52 | $0 | |
| 03/14/2023 | Q4 2022 | -$2.40 | -$0.23 | 2.17 | $0 | |
| 11/10/2022 | Q3 2022 | -$2.60 | -$0.23 | 2.37 | $0 | |
| 08/11/2022 | Q2 2022 | -$2.70 | -$0.25 | 2.45 | $0 | |
| 05/12/2022 | Q1 2022 | -$2.90 | -$0.27 | 2.63 | $0 | |
| 03/17/2022 | Q4 2021 | -$2.90 | -$0.25 | 2.65 | $0 | |
| 11/09/2021 | Q3 2021 | -$2.60 | -$0.28 | 2.32 | $0 | |
| 08/12/2021 | Q2 2021 | -$2.60 | -$0.25 | 2.35 | $0 | |
| 05/12/2021 | Q1 2021 | -$2.40 | -$0.25 | 2.15 | $0 | |
| 03/11/2021 | Q4 2020 | -$2.50 | -$0.22 | 2.28 | $0 | |
| 11/05/2020 | Q3 2020 | -$2.10 | -$0.23 | 1.87 | $0 | |
| 08/06/2020 | Q2 2020 | -$0.22 | $0 | |||
| 05/07/2020 | Q1 2020 | -$4.00 | -$0.20 | 3.8 | $0 | |
| 03/12/2020 | Q4 2019 | -$5.60 | -$0.50 | 5.1 | $0 |
Kezar Life Sciences, Inc. Earnings: Frequently Asked Questions
-
When is Kezar Life Sciences, Inc.'s earnings date?
Kezar Life Sciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based off last year's report dates.
-
Did Kezar Life Sciences, Inc. beat their earnings estimates last quarter?
In the previous quarter, Kezar Life Sciences, Inc. (:KZR) reported $-2.8 earnings per share (EPS) to beat the analysts' consensus estimate of $-3.2 by $0.4.
-
How can I listen to Kezar Life Sciences, Inc.'s earnings conference call?
The conference call for Kezar Life Sciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Kezar Life Sciences, Inc.'s conference call transcript?
The conference call transcript for Kezar Life Sciences, Inc.'s latest earnings report can be read online.
-
How much revenue does Kezar Life Sciences, Inc. generate each year?
Kezar Life Sciences, Inc. (:KZR) has a recorded annual revenue of $7.00 M.
-
How much profit does Kezar Life Sciences, Inc. generate each year?
Kezar Life Sciences, Inc. (:KZR) has a recorded net income of $7.00 M. Kezar Life Sciences, Inc. has generated $-1.4 earnings per share over the last four quarters.
-
What is Kezar Life Sciences, Inc.'s price-to-earnings ratio?
Kezar Life Sciences, Inc. (:KZR) has a price-to-earnings ratio of -5.63 and price/earnings-to-growth ratio is 0.03.
